John P. Priestle

1.7k total citations
32 papers, 1.4k citations indexed

About

John P. Priestle is a scholar working on Molecular Biology, Materials Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, John P. Priestle has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Materials Chemistry and 5 papers in Computational Theory and Mathematics. Recurrent topics in John P. Priestle's work include Protein Structure and Dynamics (8 papers), Enzyme Structure and Function (8 papers) and Computational Drug Discovery Methods (5 papers). John P. Priestle is often cited by papers focused on Protein Structure and Dynamics (8 papers), Enzyme Structure and Function (8 papers) and Computational Drug Discovery Methods (5 papers). John P. Priestle collaborates with scholars based in Switzerland, United Kingdom and Russia. John P. Priestle's co-authors include Markus G. Grütter, Peer R. E. Mittl, Stefania Di Marco, Joseph Krebs, Xu Bai, Edgar Jacoby, Kevin J. Tomaselli, Donald S. Karanewsky, Roman G. Efremov and Alexander S. Arseniev and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

John P. Priestle

32 papers receiving 1.4k citations

Peers

Countries citing papers authored by John P. Priestle

Since Specialization

Citations

This map shows the geographic impact of John P. Priestle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Priestle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Priestle more than expected).

Fields of papers citing papers by John P. Priestle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Priestle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Priestle. The network helps show where John P. Priestle may publish in the future.

Co-authorship network of co-authors of John P. Priestle

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Priestle. A scholar is included among the top collaborators of John P. Priestle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Priestle. John P. Priestle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A small molecule fusion inhibitor of dengue virus 2009 ·Antiviral Research ·Mee Kian Poh, Andy M. Yip, Summer L. Zhang, John P. Priestle, Ngai Ling, Jolanda M. Smit, Jan Wilschut, Pei‐Yong Shi, Markus R. Wenk, Wouter Schul	118
2	3-D clustering: a tool for high throughput docking 2008 ·Journal of Molecular Modeling ·John P. Priestle	3
3	Molecular Lipophilicity in Protein Modeling and Drug Design 2007 ·Current Medicinal Chemistry ·Roman G. Efremov, Anton O. Chugunov, Timothy V. Pyrkov, John P. Priestle, Alexander S. Arseniev, Edgar Jacoby	121
4	Complementarity of hydrophobic properties in ATP‐protein binding: A new criterion to rank docking solutions 2006 ·Proteins Structure Function and Bioinformatics ·Timothy V. Pyrkov, Yuri Kosinsky, Alexander S. Arseniev, John P. Priestle, Edgar Jacoby, Roman G. Efremov	22
5	Functional Profiling of Recombinant NS3 Proteases from All Four Serotypes of Dengue Virus Using Tetrapeptide and Octapeptide Substrate Libraries 2005 ·Journal of Biological Chemistry ·Jun Li, Siew Pheng Lim, David Beer, Viral Patel, Daying Wen, Christine Tumanut, David C. Tully, Jennifer Williams, Jan Jiřiček, John P. Priestle, Jennifer L. Harris, Subhash G. Vasudevan	208
6	Computational analysis of crystallization trials 2002 ·Acta Crystallographica Section D Biological Crystallography ·Glen Spraggon, Scott A. Lesley, Andreas Kreusch, John P. Priestle	46
7	The 1.2 Å crystal structure of hirustasin reveals the intrinsic flexibility of a family of highly disulphide-bridged inhibitors 1999 ·Structure ·Isabel Usón, George M. Sheldrick, Eric de La Fortelle, G. Bricogne, (unknown), John P. Priestle, (unknown), Peer R. E. Mittl	65
8	A model for the binding of low molecular weight inhibitors to the active site of thrombin 1999 ·Journal of Computer-Aided Molecular Design ·Mark C. Allen, (unknown), M.G. Gruetter, John P. Priestle	1
9	Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: Ion-dipole interactions with lysine 60G 1999 ·Bioorganic & Medicinal Chemistry Letters ·John Ambler, (unknown), Xiaoling Cockcroft, Markus G. Grütter, (unknown), (unknown), Darryl Jones, Peter D. Kane, Keith Menear, John P. Priestle, (unknown), (unknown), (unknown), Bernard Wathey	5
10	Structure of the complex of leech-derived tryptase inhibitor (LDTI) with trypsin and modeling of the LDTI–tryptase system 1997 ·Structure ·Stefania Di Marco, John P. Priestle	26
11	Recombinant hirustasin: Production in yeast, crystallization, and interaction with serine proteases 1997 ·Protein Science ·(unknown), Gabriele Fendrich, René Knecht, André Strauss, Gabriele Pohlig, Jutta Heim, John P. Priestle, Markus G. Grütter, (unknown)	8
12	Structure of Recombinant Human CPP32 in Complex with the Tetrapeptide Acetyl-Asp-Val-Ala-Asp Fluoromethyl Ketone 1997 ·Journal of Biological Chemistry ·Peer R. E. Mittl, Stefania Di Marco, Joseph Krebs, Xu Bai, Donald S. Karanewsky, John P. Priestle, Kevin J. Tomaselli, Markus G. Grütter	214
13	The crystal structure of TGF‐β3 and comparison to TGF‐β2: Implications for receptor binding 1996 ·Protein Science ·Peer R. E. Mittl, John P. Priestle, David Cox, Gary McMaster, Nico Cerletti, Markus G. Grütter	122
14	Active Site Binding Loop Stabilization in the Subtilisin Inhibitor Eglin C: Structural and Functional Studies on Specifically Designed Mutants in Complex with Subtilisin and the Uncomplexed Inhibitor 1996 ·Advances in experimental medicine and biology ·(unknown), John P. Priestle, Joseph Rahuel, Markus G. Grütter	2
15	Changes in interactions in complexes of hirudin derivatives and human α‐thrombin due to different crystal forms 1993 ·Protein Science ·John P. Priestle, Joseph Rahuel, H Rink, Michael A. Tones, Markus G. Grütter	44
16	X‐ray crystal structure of the serine proteinase inhibitor eglin c at 1.95 Å resolution 1992 ·FEBS Letters ·(unknown), John P. Priestle, Joseph Rahuel, Markus G. Grütter	22
17	Changing the inhibitory specificity and function of the proteinase inhibitor eglin c by site-directed mutagenesis: functional and structural investigation 1992 ·Biochemistry ·Dirk W. Heinz, Sven G. Hyberts, Jun Peng, John P. Priestle, Gerhard Wagner, M.G. Gruetter	38
18	Three-dimensional structure of the bifunctional enzyme phosphoribosylanthranilate isomerase: Indoleglycerolphosphate synthase from Escherichia coli refined at 2.0 Å resolution 1992 ·Journal of Molecular Biology ·Matthias Wilmanns, John P. Priestle, Thomas Niermann, Johan N. Jansonius	86
19	A Lys²⁷‐to‐Glu²⁷ mutation in the human insulin‐like growth factor‐1 prevents disulfide linked dimerization and allows secretion of BiP when expressed in yeast 1991 ·FEBS Letters ·Bhabatosh Chaudhuri, Stephen B. Helliwell, John P. Priestle	7
20	The structure of murine interleukin-1 β at 2.8 Å resolution 1991 ·Journal of Structural Biology ·Jan van Oostrum, John P. Priestle, Markus G. Grütter, Albert Schmitz	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact